title: Caveolin-1 knockout mice exhibit airway hyperreactivity.
abstract: Caveolae are flask-shaped plasma membrane invaginations expressing the scaffolding caveolin proteins. Although caveolins have been found in endothelium and epithelium (where they regulate nitric oxide synthase activity), their role in smooth muscle is still under investigation. We and others have previously shown that caveolae of human airway smooth muscle (ASM), which express caveolin-1, contain Ca(2+) and force regulatory proteins and are involved in mediating the effects of inflammatory cytokines such as TNF-α on intracellular Ca(2+) concentration responses to agonist. Accordingly, we tested the hypothesis that in vivo, absence of caveolin-1 leads to reduced airway hyperresponsiveness, using a knockout (KO) (Cav1 KO) mouse and an ovalbumin-sensitized/challenged (OVA) model of allergic airway hyperresponsiveness. Surprisingly, airway responsiveness to methacholine, tested by use of a FlexiVent system, was increased in Cav1 KO control (CTL) as well as KO OVA mice, which could not be explained by a blunted immune response to OVA. In ASM of wild-type (WT) OVA mice, expression of caveolin-1, the caveolar adapter proteins cavins 1-3, and caveolae-associated Ca(2+) and force regulatory proteins such as Orai1 and RhoA were all increased, effects absent in Cav1 KO CTL and OVA mice. However, as with WT OVA, both CTL and OVA Cav1 KO airways showed signs of enhanced remodeling, with high expression of proliferation markers and increased collagen. Separately, epithelial cells from airways of all three groups displayed lower endothelial but higher inducible nitric oxide synthase and arginase expression. Arginase activity was also increased in these three groups, and the inhibitor nor-NOHA (N-omega-nor-l-arginine) enhanced sensitivity of isolated tracheal rings to ACh, especially in Cav1 KO mice. On the basis of these data disproving our original hypothesis, we conclude that caveolin-1 has complex effects on ASM vs. epithelium, resulting in airway hyperreactivity in vivo mediated by altered airway remodeling and bronchodilation.
authors.affiliation: Department of Anesthesiology, Mayo Clinic, Rochester, MN 55905, USA.
authors.forename: Bharathi
authors.initials: B
authors.lastname: Aravamudan
authors.forename: Sarah K
authors.initials: SK
authors.lastname: VanOosten
authors.forename: Lucas W
authors.initials: LW
authors.lastname: Meuchel
authors.forename: Pawan
authors.initials: P
authors.lastname: Vohra
authors.forename: Michael
authors.initials: M
authors.lastname: Thompson
authors.forename: Gary C
authors.initials: GC
authors.lastname: Sieck
authors.forename: Y S
authors.initials: YS
authors.lastname: Prakash
authors.forename: Christina M
authors.initials: CM
authors.lastname: Pabelick
mesh_terms: D000818:Animals; D016535:Bronchial Hyperreactivity / Q000276:immunology* / Q000473:pathology; D016084:Bronchoconstriction / Q000187:drug effects / Q000276:immunology; D016085:Bronchoconstrictor Agents / Q000494:pharmacology; D002118:Calcium / Q000276:immunology; D051242:Caveolin 1 / Q000235:genetics* / Q000276:immunology*; D004195:Disease Models, Animal; D016210:Methacholine Chloride / Q000494:pharmacology; D051379:Mice; D008815:Mice, Inbred Strains; D018345:Mice, Knockout; D009130:Muscle, Smooth / Q000276:immunology; D010047:Ovalbumin / Q000276:immunology / Q000494:pharmacology; D011956:Receptors, Cell Surface / Q000235:genetics / Q000276:immunology; D047888:Receptors, Tumor Necrosis Factor, Type I / Q000235:genetics / Q000276:immunology; D020545:Respiratory Mucosa / Q000276:immunology / Q000473:pathology; D053662:Interleukin-4 Receptor alpha Subunit
chemical_list: D016085:Bronchoconstrictor Agents; D002118:Calcium; D051242:Caveolin 1; D016210:Methacholine Chloride; D010047:Ovalbumin; D011956:Receptors, Cell Surface; D047888:Receptors, Tumor Necrosis Factor, Type I; C504002:Il4ra protein, mouse; D053662:Interleukin-4 Receptor alpha Subunit; C506236:Tnfrsf1a protein, mouse